Insider Transactions in Q1 2026 at Eye Point Pharmaceuticals, Inc. (EYPT)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2026
|
George Elston Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,487
-4.66%
|
$71,792
$16.86 P/Share
|
|
Jan 06
2026
|
George Elston Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,285
+13.69%
|
-
|
|
Jan 06
2026
|
Jay S. Duker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,054
-11.45%
|
$160,864
$16.86 P/Share
|
|
Jan 06
2026
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,793
+19.15%
|
-
|
|
Jan 06
2026
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
75,133
+20.33%
|
-
|
|
Jan 05
2026
|
Ramiro Ribeiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
42,544
-100.0%
|
$723,248
$17.1 P/Share
|
|
Jan 05
2026
|
Ramiro Ribeiro Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,250
+40.74%
|
$234,000
$8.26 P/Share
|
|
Jan 05
2026
|
George Elston Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,403
-5.15%
|
$74,851
$17.43 P/Share
|
|
Jan 05
2026
|
George Elston Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+14.93%
|
-
|
|
Jan 05
2026
|
Jay S. Duker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,505
-17.79%
|
$246,585
$17.43 P/Share
|
|
Jan 05
2026
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+26.9%
|
-
|
|
Jan 05
2026
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
12,666
+5.46%
|
-
|
|
Jan 03
2026
|
Ramiro Ribeiro Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,373
-32.4%
|
$108,341
$17.48 P/Share
|
|
Jan 03
2026
|
Ramiro Ribeiro Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,667
+50.0%
|
-
|
|
Jan 03
2026
|
George Elston Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,324
-8.24%
|
$107,508
$17.48 P/Share
|
|
Jan 03
2026
|
George Elston Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,667
+20.39%
|
-
|
|
Jan 03
2026
|
Jay S. Duker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,447
-31.28%
|
$398,599
$17.48 P/Share
|
|
Jan 03
2026
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
65,000
+46.44%
|
-
|